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Diagnosis of Biofilm-Associated Peri-Implant Disease Using a FluorescenceBased Approach
Abstract
Dental implants have become a routine component of daily dental practice and the demand for dental
implants is expected to increase significantly in the future. Despite the high success rates of dental
implants, failures do occur, resulting in discomfort, rampant destruction of the oral health, or painful and
costly surgical replacement of a failed implant. Peri-implant diseases are inflammatory conditions
affecting the soft/hard tissues surrounding a functional dental implant. Plenty of experimental evidence
indicates that the accumulation of dental plaque at the soft tissue– implant interface and the subsequent
local inflammatory response seems to be key in the pathogenesis of the peri-implant mucositis. Such
peri-implant–soft tissue interface is less effective than natural teeth in resisting bacterial invasion,
enhancing vulnerability to subsequent peri-implant disease. Furthermore, in certain individuals, it will
progress to peri-implantitis, resulting in alveolar bone loss and implant failure. Although early diagnosis
and accurate identification of risk factors are extremely important to effectively prevent peri-implant
diseases, current systematic reviews revealed that a uniform classification and diagnostic methodology
for peri-implantitis are lacking. Recent progress on fluorescence-based technology enabled rapid
diagnosis of the disease and effective removal of plaques. Here, we briefly review biofilm-associated periimplant diseases and propose a fluorescence-based approach for more accurate and objective
diagnoses. A fluorescence-based diagnosis tool through headlights combined with special-filtered dental
loupes may serve as a hands-free solution for both precise diagnosis and effective removal of plaquebiofilms. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
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Abstract: Dental implants have become a routine component of daily dental practice and the demand
for dental implants is expected to increase significantly in the future. Despite the high success
rates of dental implants, failures do occur, resulting in discomfort, rampant destruction of the oral
health, or painful and costly surgical replacement of a failed implant. Peri-implant diseases are
inflammatory conditions affecting the soft/hard tissues surrounding a functional dental implant.
Plenty of experimental evidence indicates that the accumulation of dental plaque at the soft tissue–
implant interface and the subsequent local inflammatory response seems to be key in the pathogenesis
of the peri-implant mucositis. Such peri-implant–soft tissue interface is less effective than natural
teeth in resisting bacterial invasion, enhancing vulnerability to subsequent peri-implant disease.
Furthermore, in certain individuals, it will progress to peri-implantitis, resulting in alveolar bone loss
and implant failure. Although early diagnosis and accurate identification of risk factors are extremely
important to effectively prevent peri-implant diseases, current systematic reviews revealed that a
uniform classification and diagnostic methodology for peri-implantitis are lacking. Recent progress
on fluorescence-based technology enabled rapid diagnosis of the disease and effective removal of
plaques. Here, we briefly review biofilm-associated peri-implant diseases and propose a fluorescencebased approach for more accurate and objective diagnoses. A fluorescence-based diagnosis tool
through headlights combined with special-filtered dental loupes may serve as a hands-free solution
for both precise diagnosis and effective removal of plaque-biofilms.
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1. Introduction
Osseointegrated dental implants have become a reliable treatment option for replacing
missing teeth and are now a routine component of daily dental practice [1,2]. There has
been a large increase in the prevalence of patients receiving dental implants ranging from
0.7% in 2000 to 5.7% in 2016 [3]. Every year, approximately five million implants are placed
in the US as per the American Dental Association, and the global dental implant market is
expected to reach around $4.5 billion a year by 2022 [3].
Despite the high success rates of dental implants, it is challenging to maintain them in
the long term. Many studies reported relatively high frequencies of peri-implant diseases
with some variances. For example, one study surveyed 1497 participants with 6283 implants
and reported that peri-implant mucositis was found in 63.4% of participants and 30.7%
of implants, and peri-implantitis in 18.8% of participants and 9.6% of implants [4]. A
survey of periodontists in the US revealed a prevalence of peri-implant mucositis and
peri-implantitis in their practices of up to 25% [5]. Another cross-sectional study reported
the frequencies of peri-implant mucositis and peri-implantitis, in individuals, as 54%
and 28%, respectively [6]. Finally, a meta-analysis of 47 studies summarized that the
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prevalences of peri-implantitis of weighted mean implant and participant were 9.25% and
19.83%, and those of peri-implant mucositis were 29.48% and 46.83%, respectively [7]. In
summary, these studies demonstrate a high incidence of peri-implant diseases among
patients three to 18 years after implantation. Inconsistent definitions and vague criteria
for diagnosis of peri-implant disease may limit objective studying of the prevalence and
extent of peri-implant diseases. A clear definition of peri-implant mucositis and implantitis
and the development of improved diagnostic tools is warranted if study outcomes are
to be compared. This article briefly reviews biofilm-associated peri-implant diseases and
proposes a fluorescence-based approach for more accurate and objective diagnoses.
2. Definition of Peri-Implant Diseases
Peri-implant diseases are inflammatory conditions affecting the soft and hard tissues
surrounding a dental implant [8,9]. Under healthy conditions, peri-implant soft tissues
around implant-supported restorations protect the implant–bone interface around osseointegrated implants against bacterial invasion. However, the soft tissue adjacent to these
restorations has been shown to be less effective than that of natural teeth in resisting bacterial invasion due to the lack of a true connective tissue attachment and reduced vascular
supply, resulting in enhanced vulnerability to subsequent peri-implant disease [10,11].
Such peri-implant diseases are classified into two categories: peri-implant mucositis and
peri-implantitis. While clinical signs of soft tissue inflammation are observed in both
forms of peri-implant disease, alveolar bone loss that can potentially lead to implant loss is
unique to peri-implantitis [9,12]. Despite peri-implant mucositis being a relatively benign
and reversible condition [8,13], it is critical to recognize that, in some individuals, it will
progress to peri-implantitis, which may be highly destructive and irreversible. Particularly,
smokers or patients with a history of chronic periodontitis or diabetes were shown to be
more susceptible to peri-implant diseases [14–21].
3. Pathogenesis of Peri-Implant Diseases
Soft mucosal and hard dental tissues are continuously colonized by oral microbial
flora. More than 700 species are accounted for oral microbiota, while distinct subsets
are found from individual habitats [22,23]. These oral microbial cells form structured
communities called biofilms on soft and hard tissues in the oral cavity, exhibiting a highly
functionalized microbial organization [24]. These microbial communities are associated
with health or disease at distinct oral sites [25]. Changes in the local microenvironment
may trigger the overgrowth of pathogenic bacterial species, and in turn, result in a shift in
the composition of the biofilm microflora. Ultimately, this may lead to dysbiosis between
the resident oral microbiota and the host [26,27], frequently expressing virulent properties.
Dental caries and periodontal diseases are representative oral diseases, both caused
by biofilms growing on natural tooth and tooth restoration surfaces. Biofilms on the tooth
surface may demineralize the enamel, and dentine, when exposed to dietary carbohydrates such as sugars, results in fermentation and the generation of acids. Periodontal
diseases are also attributed to changes in the polymicrobial biofilms accumulated on the
tooth surface in the subgingival area. The thickened biofilm results in the destruction
of the tooth-supporting (periodontal) tissues as a result of the excessive host-modulated
inflammatory response to the biofilm from the juxtaposed gingival tissue. Persistence and
progression of a heightened inflammatory response can result in enzymatic destruction of
the deeper periodontal tissues that link the tooth surface to the supporting alveolar bone.
If untreated, periodontitis will eventually result in tooth loss. Similarly, a significant body
of experimental evidence indicates that peri-implant mucositis is also caused by the accumulation of bacterial biofilms (dental plaque) at the soft tissue–implant interface [28–31].
In addition, the ensuing local inflammatory response is being considered as a key in the
pathogenesis of the peri-implant diseases. In general, microbial cells in mature biofilms are
more resistant to antibiotics compared to those in a planktonic phase, since biofilms act
as a protective barrier by limiting penetration of neutrophils, antibodies, or antimicrobial
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factors into a deeper area of biofilms [32–34]. Thus, optimal daily biofilm removal with adequate supportive periodontal therapy effectively prevents peri-implant mucositis, thereby
decreasing the risk for peri-implantitis.
4. Current Knowledge of Oral Microbiology (Biofilms) Associated with
Peri-Implant Mucositis
Previous studies showed that representative periodontopathic bacteria in periodontal
pockets of residual teeth are highly associated with their presence in peri-implant pockets,
due to the similarity of the peri-implant and periodontal sulcus environments [35–39].
Therefore, those representative periodontopathic bacteria, Porphyromonas gingivalis, Treponema denticola, Tannerella forsythensis, and Aggregatibacter actinomycetemcomitans [40–42],
were considered as a risk indicator for peri-implant mucositis [43,44]. Yet, there are increasing reports showing the disparity of microbiota between peri-implant and periodontal
diseases depending on the detection method of the microbiome and the range of species
targeted [37,45]. For example, Koyanagi et al. reported that the biofilm in peri-implantitis
showed a more complex microbial composition when compared with periodontitis [46].
They observed that Fusobacterium spp. and Streptococcus spp. were predominant in both
peri-implantitis and periodontitis sites, while Parvimonas micra was exclusively detected in
peri-implantitis [46]. By evaluating the whole microbiome via genomic sequencing, more
uncultivable bacteria such as asaccharolytic anaerobic Gram-positive and Gram-negative
rods as well as opportunistic microorganisms including enteric rods and Staphylococcus
aureus were found in peri-implantitis sites, which were not frequently identified in teeth
with periodontitis or healthy implants [45].
Additionally, previous microbiological studies assessed the composition of microbiota
around implants and natural teeth. Interestingly, there were no statistical differences in
the bacterial population nor microflora around implants and antagonist natural teeth [47].
However, some major periodontopathic microorganisms of red complex (e.g., P. gingivalis)
and orange complex (e.g., Prevotella intermedia) were detected significantly more from
implants affected by peri-implantitis than those not affected [47]. It indicates that the
prognosis of peri-implant diseases can be achieved by detecting those periodontopathic
microorganisms from implants.
5. Current Diagnosis and Treatment of Peri-Implant Diseases
Despite the fact that early diagnosis and accurate identification of risk factors are extremely important to effectively prevent peri-implant diseases, current systematic reviews
revealed that a uniform classification and diagnostic methodology for peri-implantitis
are lacking [48,49]. The 2017 World Workshop on the classification of periodontal and
peri-implant diseases and conditions provided specific criteria to accurately define periimplant status [50]. However, the diagnosis of peri-implant disease is heavily relying
on clinical and radiographic data, which are neither sufficient nor sensitive to detect the
disease at the initial phase [42]. For example, bleeding on probing, an indicator of inflammation in the peri-implant mucosa, has been considered a key clinical measure to
distinguish between peri-implant health and disease. However, the case definition for
peri-implantitis varied significantly between studies (e.g., probing depth and bleeding on
probing), resulting in inconsistent distinction between health and disease [51]. Notably,
there is no microbiological criterium in diagnosing peri-implant disease yet, although
microbial infection at the interface of gingival tissue and implant is one of the primary
causes of peri-implant diseases.
While the lack of regular supportive therapy in patients with peri-implant mucositis
can escalate the risk for onset of peri-implantitis, there is no documented protocol available
for the primary prevention of peri-implant mucositis. A variety of methods including
air-powder abrasion, saline wash, citric acid application, laser therapy, peroxide treatment,
ultrasonic/manual debridement, and application of topical medication have been applied
to attempt to decontaminate the peri-implant sites. However, a definite gold standard could
not be identified yet [52]. It has been shown that experimental peri-implant mucositis was
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significantly reversed via three weeks of professionally administered plaque removal and
reinstitution of oral hygiene practices [29], indicating that the resolution of peri-implant
mucositis is achievable. Therefore, the elimination of the plaque-biofilm from the implant
surface should be the prime objective when treating peri-implantitis [52]. Indeed, patientadministered mechanical plaque control with manual or powered toothbrushes appeared
to be an effective preventive measure. Additionally, professional interventions such as
oral hygiene practices and mechanical debridement revealed a reduction in clinical signs
of inflammation. In contrast, adjunctive measures (e.g., antiseptics, local and systemic
antibiotics, air-abrasive devices) did not significantly improve the efficacy of professionally
administered plaque removal procedures in reducing clinical signs of inflammation [53].
Since the failure of treating peri-implant mucositis may lead to progression of the periimplant lesion or the bone loss that requires surgical therapy [52,54], a novel method
for accurately diagnosing peri-implant mucositis at an early phase in conjunction with
professionally administered plaque removal procedures is warranted.
6. Fluorescence-Based Early Detection of Peri-Implant Diseases
While early detection of peri-implant mucositis is critical to effectively prevent further
progression to peri-implantitis, current peri-implant health diagnosis (e.g., bleeding on
probing) fails to adequately predict disease progression [55]. As such, a need for pointof-care diagnosis has been described by many researchers and mirrors the needs of daily
clinical practice. Fluorescence-based technology has the potential to be applied for the
diagnosis and effective removal of plaques. Since light (photons) can propagate through
the crystalline enamel and dentine tubules, changes in the mineral contents of teeth can be
measured using light-scattering phenomena [56,57]. For instance, once the hard tissue is
demineralized, the ultrastructure of enamel and dentine are changed; thereby, a distinct
optical signal is garnered due to the modified light-tissue interactions [57–59]. In addition,
some biological tissues can absorb and re-emit specific light wavelengths [60,61]. Thus,
this technology can be used to assess the amount of bacteria or their metabolic activity.
Indeed, the applicability of fluorescence spectroscopy for the detection of calculus and
plaque has been confirmed by several research groups using wavelengths from 360 up to
580 nm for excitation and different filters for the emission spectra [62–65]. For example,
red and green autofluorescence glow of plaque has been observed from both in vitro and
in vivo research studies [66–69]. Additionally, fluorescence glow around and on dental
implants has been described and explained as a result of plaque, bacteria-contaminated
calculus, and pentosidine [70]. It is worth noting that specific pathogenic bacteria could be
diagnosed and differentiated from mature biofilms by detecting orange-to-red fluorescence
porphyrins produced by peri-implant pathogens P. gingivalis and A. actinomicetemcomitans.
As discussed earlier, microbiome composition is distinct between the implant with and
without peri-implantitis. Implants affected by peri-implantitis harbor more red and orange
complex bacteria. Therefore, utilizing fluorescence methodology may be a pragmatic
way of diagnosing the potential incidence of peri-implantitis without a more complicated
analysis method such as microbiome analysis or microCT.
Figure 1 shows an implant that failed due to peri-implantitis under natural and
ultraviolet (UV) lights. As shown, plaque and active bacteria become distinct under
UV light, which may enable proper differential diagnosis of peri-implant disease and
facilitates accurate plaque removal. Furthermore, a fluorescence-based detection method
can be used for not only the detection before the treatment but also the confirmation of
successful debridement after the treatment. Completion of the biofilm elimination could
be confirmed by visually inspecting the disappearance of the fluorescent from affected
surfaces. Collectively, utilization of the fluorescence property of bacteria for point of care
identification is a highly attractive new methodology with a wide spectrum of applications.
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